Research Rheum

Study Points to Need for Increased Antirheumatic Therapy in Patients with Dyslipidemia

Lara C. Pullen, PhD | October 4, 2013

A new study suggests that patients diagnosed with RA as well as dyslipidemia may benefit from more aggressive antirheumatic therapy. (posted Oct. 3, 2013)

Immunology Research Pioneers Receive Carol Nachman Prize

Amanda Rillo | October 1, 2013

Rheumatologists Gerd R. Burmester, MD, of Berlin, and Michael B. Brenner, MD, of Boston, honored with prestigious international award

Rheumatology Research Foundation Advances Studies in Inflammatory Arthritis

Staff | October 1, 2013

Disease Targeted Research Initiative may improve treatment, prevention of rheumatoid arthritis, other inflammatory diseases

New Insights into CPPD

Robert Terkeltaub, MD | October 1, 2013

Progress in research, outcomes, diagnosis, and treatment of calcium pyrophosphate dihydrate crystal deposition disease

Lactoferricin’s Role in Preventing Disc Degeneration

Lara C. Pullen, PhD | September 16, 2013

The combination of bone-morphogenetic protein-7 (BMP7) and lactoferricin B (LfcinB) may be a useful treatment for disc degeneration. (posted Sept. 16, 2013)

Sensory Nerves May Be Key for Osteoporosis

Lara C. Pullen, PhD | September 10, 2013

Sensory nerves have an essential role in bone remodeling. In particular, semaphorin 3A (Sema3A) regulates bone remodeling by modulating sensory nerve development. (posted Sept. 9, 2013)

Rheumatology Research Foundation Announces 2013 Awards and Grants Recipients

Staff | September 1, 2013

The Foundation names winners of education and training awards, career development research awards, and disease-targeted research grants

ACR Research Conferences to Focus on Rheumatic Diseases

Staff | September 1, 2013

The ACR’s Basic Research Conference and Clinical Research Conference on October 25–26 to feature new perspectives on development of rheumatoid arthritis, lupus, and vasulitis, and review current thinking on preclinical rheumatic disease

EULAR 2013: Research Hints at Risk Factors for Rheumatoid Arthritis

Thomas R. Collins | September 1, 2013

Studies point to involvement of anti-CCP antibodies and citrullinated targets in the lungs and joints in the development of RA, and suggest an early therapeutic window for prevention

New Methodology to Improve Cartilage Repair

Lara C. Pullen, PhD | July 31, 2013

A single treatment with recombinant acid ceramidase improves the chondrogenic phenotype of primary chondrocytes and leads to an increased yield of mesenchymal stem cells. (posted July 31, 2013)